Literature DB >> 34172274

The Ganzflicker experience: High probability of seeing vivid and complex pseudo-hallucinations with imagery but not aphantasia.

Varg T Königsmark1, Johanna Bergmann2, Reshanne R Reeder3.   

Abstract

There are considerable individual differences in visual mental imagery ability across the general population, including a "blind mind's eye", or aphantasia. Recent studies have shown that imagery is linked to differences in perception in the healthy population, and clinical work has found a connection between imagery and hallucinatory experiences in neurological disorders. However, whether imagery ability is associated with anomalous perception-including hallucinations-in the general population remains unclear. In the current study, we explored the relationship between imagery ability and the anomalous perception of pseudo-hallucinations (PH) using rhythmic flicker stimulation ("Ganzflicker"). Specifically, we investigated whether the ability to generate voluntary imagery is associated with susceptibility to flicker-induced PH. We additionally explored individual differences in observed features of PH. We recruited a sample of people with aphantasia (aphants) and imagery (imagers) to view a constant red-and-black flicker for approximately 10 min. We found that imagers were more susceptible to PH, and saw more complex and vivid PH, compared to aphants. This study provides the first evidence that the ability to generate visual imagery increases the likelihood of experiencing complex and vivid anomalous percepts.
Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Aphantasia; Hallucinations; Individual differences; Mental imagery; Visual flicker

Mesh:

Year:  2021        PMID: 34172274     DOI: 10.1016/j.cortex.2021.05.007

Source DB:  PubMed          Journal:  Cortex        ISSN: 0010-9452            Impact factor:   4.027


  1 in total

Review 1.  Forgotten rhythms? Revisiting the first evidence for rhythms in cognition.

Authors:  Cliodhna Quigley
Journal:  Eur J Neurosci       Date:  2021-09-29       Impact factor: 3.698

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.